Phagenyx® for patients & families

Phagenyx is a non-surgical therapy that helps restore safe, effective swallowing and supports faster recovery for patients with severe dysphagia after a stroke

Learn more

A New Way to Support Swallowing Recovery

Dysphagia is the medical term for difficulty swallowing, which is common after stroke, brain injury, or serious illness. It can lead to longer hospital stays and serious health risks like food or liquid entering the airway. Traditional treatments may not fully treat the brain pathways involved in swallowing, which can slow down recovery.

Pharyngeal electrical stimulation (PES) is a targeted therapy that delivers small electrical pulses to the swallowing nerves in the throat to re-establish the communication between these nerves and the brain.

Phagenyx is the first treatment of its kind to use pharyngeal electrical stimulation (PES) to help retrain the brain and restore safe, effective swallowing. This non-surgical therapy is delivered at the bedside in just a few minutes a day and is designed to support a faster, safer recovery for people with severe swallowing difficulty.

How Phagenyx Works

Phagenyx uses pharyngeal electrical stimulation (PES) to retrain the brain and restore swallowing control.

Stimulation of swallowing nerves

Swallowing control is restored

Signals transmitted to the brain

Brain relearns how to swallow

Swallowing control is restored

Stroke Recovery Starts Here

Phagenyx helps restore safe swallowing and support faster recovery.

Faster return to a more normal diet

Improvement in swallowing safety

Fewer days in the hospital

Additional Resources

Questions?

Treatment Questions

Phagenyx treatment is only available to hospital in-patients with severe dysphagia following a stroke. It is not currently available on an outpatient basis. Treatment is delivered by a trained clinician and is not approved for home use.

Patients may feel a tingling sensation in their throat during treatment. Stimulation levels are tested prior to treatment to ensure it is strong but tolerable.

No, Phagenyx treatment does not require surgery.

Availability Questions

Phagenyx is indicated for the treatment of severe dysphagia following stroke. Its use in patients post-cancer treatment is considered off-label. We do not have any published data in this patient population.

Phagenyx is indicated for the treatment of severe dysphagia following stroke. Treatment of patients with Parkinson’s disease is considered off-label. We do not have any published data in this patient population.

Phagenyx is indicated for adult patients only. We do not have safety or efficacy data in pediatric patients (18 years old or younger), so use of Phagenyx would be considered off-label.